LEVOBUPIVACAINE ALTAN 1.25 mg/ml, solution for infusion 12 bags of 200 ml
Active ingredients: Levobupivacaine hydrochloride, Levobupivacaine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusion12 bags of 200 mlpéridurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVOBUPIVACAINE ALTAN 1,25 mg/mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- péridurale
- Presentation description
- 12 poches polypropylène souple suremballées/surpochées aluminium de 200 mL
- Marketing authorisation holder
- ALTAN PHARMACEUTICALS (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66681599CIP75506030CIP133400955060307Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LÉVOBUPIVACAÏNEsolution | — | SA |
| LÉVOBUPIVACAÏNEsolution | 1,25 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.